J9053 Injection, belantamab mafodotin-blmf, 0.1 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj belantamab mafodot blmf
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, belantamab mafodotin-blmf, 0.1 mg | yes |
Related codes in J90
- J9000 Injection, doxorubicin hydrochloride, 10 mg
- J9003 Leuprolide injectable (camcevi etm), 1 mg
- J9011 Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 Injection, aldesleukin, per single use vial
- J9017 Injection, arsenic trioxide, 1 mg
- J9021 Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 Injection, atezolizumab, 10 mg
- J9023 Injection, avelumab, 10 mg
- J9024 Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 Injection, azacitidine, 1 mg
- J9026 Injection, tarlatamab-dlle, 1 mg
- J9027 Injection, clofarabine, 1 mg
- J9028 Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029 Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9030 Bcg live intravesical instillation, 1 mg
- J9032 Injection, belinostat, 10 mg
- J9033 Injection, bendamustine hydrochloride, 1 mg
- J9034 Injection, bendamustine hcl (bendeka), 1 mg
- J9035 Injection, bevacizumab, 10 mg
- J9036 Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg